Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Outcome and Prognostic Factors in Bronchial Carcinoids A Single-Center Experience

Outcome and Prognostic Factors in Bronchial Carcinoids A Single-Center Experience OrIGINAL Ar TICLE Outcome and Prognostic Factors in Bronchial Carcinoids A Single-Center Experience Pier Luigi Filosso, MD, FETCS, FCCP,* Alberto Oliaro, MD, FETCS,* Enrico Ruffini, MD, FETCS,* Giulia Bora, MD,* Paraskevas Lyberis, MD,* Sofia Asioli, MD, †Luisa Delsedime, MD,† Alberto Sandri MD,* and Francesco Guerrera, MD* subdivided into a spectrum of preinvasive lesions, from NE Introduction: The aim of this study is to assess factors influencing cell hyperplasia to tumorlets but, as this subdivision is not survival in patients with bronchial carcinoids (BCs). yet completely understood, its real clinical significance is still Methods: A retrospective review of our surgical database of patients 3,4 matter of debate. operated for primary lung cancer with a final histologic diagnosis of BCs are considered rare tumors with an annual inci- BC in the period from January 1, 1995 to December 31, 2010 was dence comprising between 2.3 and 2.8 cases per 1 million carried out. 5 6 people ; they include 20% to 25% of all carcinoid tumors but Results: There were 126 patients (74 women): 83 had a typical car- 7,8 account to only 0.4% to 3% of all primary lung cancers. cinoid and 43 an atypical one (AC). All patients received a radical Nearly 10% of BCs http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Outcome and Prognostic Factors in Bronchial Carcinoids A Single-Center Experience

Journal of Thoracic Oncology , Volume 8 (10) – Oct 1, 2013

Loading next page...
 
/lp/wolters-kluwer-health/outcome-and-prognostic-factors-in-bronchial-carcinoids-a-single-center-ObS52PVYju

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2013 by the International Association for the Study of Lung Cancer
ISSN
1556-0864

Abstract

OrIGINAL Ar TICLE Outcome and Prognostic Factors in Bronchial Carcinoids A Single-Center Experience Pier Luigi Filosso, MD, FETCS, FCCP,* Alberto Oliaro, MD, FETCS,* Enrico Ruffini, MD, FETCS,* Giulia Bora, MD,* Paraskevas Lyberis, MD,* Sofia Asioli, MD, †Luisa Delsedime, MD,† Alberto Sandri MD,* and Francesco Guerrera, MD* subdivided into a spectrum of preinvasive lesions, from NE Introduction: The aim of this study is to assess factors influencing cell hyperplasia to tumorlets but, as this subdivision is not survival in patients with bronchial carcinoids (BCs). yet completely understood, its real clinical significance is still Methods: A retrospective review of our surgical database of patients 3,4 matter of debate. operated for primary lung cancer with a final histologic diagnosis of BCs are considered rare tumors with an annual inci- BC in the period from January 1, 1995 to December 31, 2010 was dence comprising between 2.3 and 2.8 cases per 1 million carried out. 5 6 people ; they include 20% to 25% of all carcinoid tumors but Results: There were 126 patients (74 women): 83 had a typical car- 7,8 account to only 0.4% to 3% of all primary lung cancers. cinoid and 43 an atypical one (AC). All patients received a radical Nearly 10% of BCs

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Oct 1, 2013

There are no references for this article.